A Phase 1 study of AMG 732 in healthy participants and thyroid eye disease patients

Study Description

A Study of an Investigational Drug (AMG 732) for Thyroid Eye Disease

Study Details

Registry ID:

NCT06401044

Conditions:

Thyroid Eye Disease

Phase:

Phase 1,Phase 2

Target Enrollment:

94 participants

Start Date:

May 30, 2024

Age Range:

18–65 years

Healthy Volunteers:

No

Study Locations (46 sites)

• Hospital Universitario Virgen Macarena
  Seville, AndalusiaSpain, Spain
• Hospital Universitari i Politecnic La Fe
  ValenciaSpain, Spain
• Hospital Universitario Ramon y Cajal
  MadridSpain, Spain
• Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico
  MilanItaly, Italy
• General Hospital of Athens Laiko
  AthensGreece, Greece
• Azienda Ospedaliero Universitaria Pisana
  PisaItaly, Italy
• Azienda Socio Sanitaria Territoriale dei Sette Laghi
  VareseItaly, Italy
• Ippokratio General Hospital of Thessaloniki
  ThessalonikiGreece, Greece
• Centre Hospitalier Universitaire de Nantes - Hopital Nord Laennec
  NantesFrance, France
• Universitaetsklinikum Freiburg
  Freiburg im BreisgauGermany, Germany
• Hopital Pitie-Salpetriere
  ParisFrance, France
• Buergerhospital und Clementine Kinderhospital gGmbH
  Frankfurt am MainGermany, Germany
• Universitaetsklinikum Essen
  EssenGermany, Germany
• Universitaetsklinikum Leipzig AoeR
  LeipzigGermany, Germany
• Dc-Med Spolka z Ograniczona Odpowiedzialnoscia Spolka Komandytowa
  SwidnicaPoland, Poland
• Uniwersyteckie Centrum Stomatologii I Medycyny Specjalistycznej Spzoo
  PoznanPoland, Poland
• Eb Group Spolka z ograniczona odpowiedzialnoscia
  WarsawPoland, Poland
• Profesorskie Centrum Medyczne Spolka z Ograniczona Odpowiedzialnoscia
  GdanskPoland, Poland
• Massachusetts Eye and Ear Infirmary
  Boston, MassachusettsUnited States, United States
• CHU de Québec-Université Laval - CUO-Recherche Clinique, Hopital du Saint-Sacrement
  Québec, QuebecCanada, Canada
• Ilumina Medical Research
  Kissimmee, FloridaUnited States, United States
• Santé Québec Est-de-l'Île-de-Montréal - Universitaire
  Montreal, QuebecCanada, Canada
• CIUSSS de lest de lile de Montreal - Hôpital Maisonneuve Rosemont
  Montreal, QuebecCanada, Canada
• Sarasota Retina Institute
  Sarasota, FloridaUnited States, United States
• Levenson Eye Associates
  Jacksonville, FloridaUnited States, United States
• West Virginia University
  Morgantown, West VirginiaUnited States, United States
• Erie Retina Research
  Erie, PennsylvaniaUnited States, United States
• Vision Medical Research, Inc.
  Orland Park, IllinoisUnited States, United States
• Applied Research Center of Arkansas
  Little Rock, ArkansasUnited States, United States
• Baylor College of Medicine Medical Center
  Houston, TexasUnited States, United States
• Consano Clinical Research, LLC
  Shavano Park, TexasUnited States, United States
• Singapore National Eye Centre
  SingaporeSingapore, Singapore
• National University Hospital
  SingaporeSingapore, Singapore
• Ppd Las Vegas Research Unit
  Las Vegas, NevadaUnited States, United States
• Amy Patel Jain MD
  Newport Beach, CaliforniaUnited States, United States
• Taipei Veterans General Hospital
  TaipeiTaiwan, Taiwan
• National Taiwan University Hospital
  TaipeiTaiwan, Taiwan
• Vancouver General Hospital
  Vancouver, British ColumbiaCanada, Canada
• Hayashi Eye Hospital
  Fukuoka, FukuokaJapan, Japan
• University of Miyazaki Hospital
  Miyazaki, MiyazakiJapan, Japan
• Aichi Medical University Hospital
  Nagakute-shiJapan, Japan
• Kozawa Eye Hospital And Diabetes Center
  Mito, IbarakiJapan, Japan
• Macquarie University
  North Ryde, New South WalesAustralia, Australia
• North Shore Private Hospital
  St Leonards, New South WalesAustralia, Australia
• North Shore Private Hospital
  Saint Leonards, New South WalesAustralia, Australia
• Macquarie University Hospital
  Sydney, New South WalesAustralia, Australia

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →